EWTX
Price
$39.91Alerts
Change
-$1.27 (-3.08%)
Updated
Nov 20 closing price
Capitalization
4.89B
96 days until earnings call
Intraday BUY SELL Signals
MNPR
Price
$69.00Alerts
Change
-$1.29 (-1.84%)
Updated
Nov 20 closing price
Capitalization
479.38M
124 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

EWTX vs MNPR

EWTX vs MNPR Comparison Chart in %
View a ticker or compare two or three
VS
EWTX vs. MNPR commentary
Nov 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EWTX is a Hold and MNPR is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for EWTX with price predictions
Nov 20, 2026

EWTX in -3.54% downward trend, declining for three consecutive days on November 20, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where EWTX declined for three days, in 256 of 302 cases, the price declined further within the following month. The odds of a continued downward trend are 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for EWTX moved out of overbought territory on November 12, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 22 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 85%.

The Momentum Indicator moved below the 0 level on November 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EWTX as a result. In 83 of 100 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.

The Moving Average Convergence Divergence Histogram (MACD) for EWTX turned negative on November 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 41 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.

EWTX moved below its 50-day moving average on November 19, 2026 date and that indicates a change from an upward trend to a downward trend.

EWTX broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The 10-day moving average for EWTX crossed bullishly above the 50-day moving average on November 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 87%.

Following a +25.39% 3-day Advance, the price is estimated to grow further. Considering data from situations where EWTX advanced for three days, in 236 of 277 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

The Aroon Indicator entered an Uptrend today. In 173 of 188 cases where EWTX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.917) is normal, around the industry mean (3.596). P/E Ratio (-24.346) is within average values for comparable stocks, (-1.186). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.158). Dividend Yield (0.000) settles around the average of (131.631) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (443.347).

The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. EWTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 41 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is 69 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for MNPR with price predictions
Nov 20, 2026

MNPR saw its Stochastic Oscillator recovers from the overbought zone

The Stochastic Oscillator for MNPR moved out of overbought territory on November 12, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 50 similar instances where the indicator exited the overbought zone. In 45 of the 50 cases the stock moved lower. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MNPR as a result. In 71 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MNPR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for MNPR entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MNPR's RSI Indicator exited the oversold zone, 25 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

The Moving Average Convergence Divergence (MACD) for MNPR just turned positive on October 20, 2026. Looking at past instances where MNPR's MACD turned positive, the stock continued to rise in 38 of 42 cases over the following month. The odds of a continued upward trend are 90%.

Following a +9.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where MNPR advanced for three days, in 223 of 266 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

MNPR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 6 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.663) is normal, around the industry mean (3.596). P/E Ratio (-32.464) is within average values for comparable stocks, (-1.186). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.158). Dividend Yield (0.000) settles around the average of (131.631) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (443.347).

The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 48 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. MNPR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
MNPR: Fundamental Ratings
MNPR
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
6
Undervalued
PROFIT vs RISK RATING
1..100
48
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
15
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EWTXMNPR
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
85%
Bullish Trend 13 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Nov 22, 2026
Stock price -- (EWTX: $39.90 vs. MNPR: $69.00)
Brand notoriety: EWTX and MNPR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EWTX: 51% vs. MNPR: 105%
Market capitalization -- EWTX: $4.89B vs. MNPR: $479.38M
EWTX [@Biotechnology] is valued at $4.89B. MNPR’s [@Biotechnology] market capitalization is $479.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EWTX’s FA Score shows that 1 FA rating(s) are green while MNPR’s FA Score has 2 green FA rating(s).

  • EWTX’s FA Score: 1 green, 4 red.
  • MNPR’s FA Score: 2 green, 3 red.
According to our system of comparison, MNPR is a better buy in the long-term than EWTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EWTX’s TA Score shows that 4 TA indicator(s) are bullish while MNPR’s TA Score has 4 bullish TA indicator(s).

  • EWTX’s TA Score: 4 bullish, 6 bearish.
  • MNPR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MNPR is a better buy in the short-term than EWTX.

Price Growth

EWTX (@Biotechnology) experienced а -13.12% price change this week, while MNPR (@Biotechnology) price change was -4.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.58%. For the same industry, the average monthly price growth was -18.26%, and the average quarterly price growth was -28.15%.

Reported Earning Dates

EWTX is expected to report earnings on Feb 25, 2027.

MNPR is expected to report earnings on Mar 25, 2027.

Industries' Descriptions

@Biotechnology (-11.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

EWTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, EWTX has been loosely correlated with COGT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if EWTX jumps, then COGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EWTX
1D Price
Change %
EWTX100%
-3.07%
COGT - EWTX
45%
Loosely correlated
-3.70%
SLDB - EWTX
41%
Loosely correlated
-2.95%
TRVI - EWTX
39%
Loosely correlated
-2.70%
MNPR - EWTX
39%
Loosely correlated
-1.84%
FDMT - EWTX
38%
Loosely correlated
-4.57%
More

MNPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNPR has been loosely correlated with IMVT. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MNPR jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNPR
1D Price
Change %
MNPR100%
-1.84%
IMVT - MNPR
41%
Loosely correlated
-2.31%
FDMT - MNPR
41%
Loosely correlated
-4.57%
BNTC - MNPR
40%
Loosely correlated
-2.76%
IMNM - MNPR
40%
Loosely correlated
-5.54%
SLDB - MNPR
40%
Loosely correlated
-2.95%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MBINL22.210.11
+0.50%
Merchants Bancorp
OCFC17.21-0.21
-1.21%
OceanFirst Financial Corp
STLN3.00-0.18
-5.66%
Starling Oncology Institute Inc
TZOO4.96-0.31
-5.88%
Travelzoo
IREN11.82-2.59
-17.97%
IREN Limited